Topic: preventive vaccines
As questions swirl over who knew what and when in the Philippines regarding Sanofi's dengue vaccine, the company took a chance Wednesday to pause and explain its case.
Gavi's vaccine initiative will have saved 20 million lives and $350 billion in healthcare costs by 2020, a recent study found.
A global shortage of hepatitis B vaccine has developed as both Merck & Co. and GlaxoSmithKline deal with manufacturing issues.
U.S. Merck's shingles vaccine Zostavax faces a growing challenge in court.
Sun Pharma licensed a home-grown dengue fever vaccine that it hopes will rival Sanofi's Dengvaxia, which was recently delayed in India.
Plans are being laid for India and the U.S. to work together on the development of vaccines for dengue fever and other diseases that pose a major threat to public health.
As the Zika epidemic rages on, scientists are racing to develop vaccines that could quell outbreaks and prevent infections in humans. Now, a group of researchers is making progress toward this goal after three vaccines warded off Zika in primates.
Scientists have been developing vaccines that could stop disease outbreaks more quickly. Now, researchers at the Massachusetts Institute of Technology are moving ahead with easy-to-make experimental jabs that can ward off a variety of diseases.